Tarceva Trial EORTC 55041

Trial Description: 
A randomised, multicentre, phase III study of Erlotinib versus observation in patients with no evidence of disease progression after first line, platinum-based chemotherapy for high-risk Stage I and Stage II-IV ovarian epithelial, primary peritoneal, or fallopian tube cancer.
Lead Cooperative Group: 
Disease Site: 
Ovarian
Trial Status: 
Completed